Drugs causing dyslipoproteinemia

被引：39

作者：

Donahoo, WT ^{[1
]}

Kosmiski, LA ^{[1
]}

Eckel, RH ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol Diabet & Metab, Denver, CO 80262 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 1998年 / 27卷 / 03期

关键词：

D O I：

10.1016/S0889-8529(05)70033-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several classes of drugs are known to cause dyslipidemia. Recognition of these drugs is essential in the evaluation and treatment of patients with dyslipidemia. This article reviews the major classes of drugs that cause dyslipidemia (including antihypertensives, steroid hormones, drugs used in organ transplantation, retinoids, and lipid infusions) and details, when known, the mechanisms for the effects of each class of drugs. Finally, recommendations are given for the management of dyslipidemia following transplantation.

引用

页码：677 / +

页数：23

共 166 条

[11] METABOLIC AND BEHAVIORAL-EFFECTS OF HIGH-DOSE, EXOGENOUS TESTOSTERONE IN HEALTHY-MEN [J].

BAGATELL, CJ ;

HEIMAN, JR ;

MATSUMOTO, AM ;

RIVIER, JE ;

BREMNER, WJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) :561-567

[12] Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].

BakkerArkema, RG ;

Davidson, MH ;

Goldstein, RJ ;

Davignon, J ;

Isaacsohn, JL ;

Weiss, SR ;

Keilson, LM ;

Brown, WV ;

Miller, VT ;

Shurzinske, LJ ;

Black, DM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133

[13] HYPERLIPIDEMIA AFTER HEART-TRANSPLANTATION - REPORT OF A 6-YEAR EXPERIENCE, WITH TREATMENT RECOMMENDATIONS [J].

BALLANTYNE, CM ;

RADOVANCEVIC, B ;

FARMER, JA ;

FRAZIER, OH ;

CHANDLER, L ;

PAYTONROSS, C ;

COCANOUGHER, B ;

JONES, PH ;

YOUNG, JB ;

GOTTO, AM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) :1315-1321

[14] EFFECTS OF CYCLOSPORINE THERAPY ON PLASMA-LIPOPROTEIN LEVELS [J].

BALLANTYNE, CM ;

PODET, EJ ;

PATSCH, WP ;

HARATI, Y ;

APPEL, V ;

GOTTO, AM ;

YOUNG, JB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (01) :53-56

[15] A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE [J].

BARRETTCONNOR, E ;

KHAW, KT ;

YEN, SSC .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1519-1524

[16] POSTMENOPAUSAL ESTROGEN USE AND HEART-DISEASE RISK-FACTORS IN THE 1980S - RANCHO-BERNARDO, CALIF, REVISITED [J].

BARRETTCONNOR, E ;

WINGARD, DL ;

CRIQUI, MH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (14) :2095-2100

[17] ENDOGENOUS SEX-HORMONES AND CARDIOVASCULAR-DISEASE IN MEN - A PROSPECTIVE POPULATION-BASED STUDY [J].

BARRETTCONNOR, E ;

KHAW, KT .

CIRCULATION, 1988, 78 (03) :539-545

[18] Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs [J].

BarrientosVega, R ;

SanchezSoria, MM ;

MoralesGarcia, C ;

RobasGomez, A ;

CuenaBoy, R ;

AyensaRincon, A .

CRITICAL CARE MEDICINE, 1997, 25 (01) :33-40

[19]

BASTANI B, 1995, CLIN TRANSPLANT, V9, P340

[20]

BECKER DM, 1988, AM J MED, V85, P632

← 1 2 3 4 5 6 7 8 9 10 →